FDA Inspection 1214331 — Novotech (Australia) Pty Limited

Novotech (Australia) Pty Limited — FEI 3009050356

The FDA completed an inspection of Novotech (Australia) Pty Limited on July 26, 2023 in Pyrmont. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 26, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pyrmont (Australia)

Additional Details

Sponsor, Contract Research Organization